Warning: The Last Value Play Gone After August?

From Oxford Club | Ad

In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward

Get the Details Now.

LJPC Insider Trading (La Jolla Pharmaceutical)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 36.30%

Insider Buying (Last 12 Months): $1,219,339.74

Insider Selling (Last 12 Months): $1,456,970.60

La Jolla Pharmaceutical Insider Trading History Chart

La Jolla Pharmaceutical Share Price & Price History

^$3.94

▼ -0.12 (-2.96%)

As of 05/20/2022 01:00 AM ET

Days: 30 | 90 | 365

Warning: The Last Value Play Gone After August?

From Oxford Club | Ad

Get the Details Now.

La Jolla Pharmaceutical Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/6/2021	David A. Ramsay	Director	Buy	10,000	$3.82	$38,200.00
12/3/2021	David A. Ramsay	Director	Buy	4,399	$3.66	$16,100.34
12/1/2021	Kevin C Tang	Director	Sell	177,545	$3.74	$664,018.30
11/29/2021	Kevin C Tang	Director	Sell	193,403	$4.10	$792,952.30
6/1/2021	Kevin C Tang	Director	Buy	59,092	$4.47	$264,141.24
5/27/2021	Kevin C Tang	Director	Buy	185,928	$4.47	$831,098.16
5/24/2021	David A. Ramsay	Director	Buy	20,000	$3.49	$69,800.00	51,000
9/8/2020	Kevin C Tang	Director	Buy	84,152	$3.90	$328,192.80
9/4/2020	Kevin C Tang	Director	Buy	67,552	$3.82	$258,048.64
8/24/2020	David A. Ramsay	Director	Buy	47,000	$3.99	$187,530.00
8/14/2020	Kevin C Tang	Director	Buy	431,647	$3.72	$1,605,726.84
6/4/2020	Kevin C Tang	Director	Buy	615,129	$5.01	$3,081,796.29
6/2/2020	Kevin C Tang	Director	Buy	253,553	$4.88	$1,237,338.64
2/3/2020	Kevin C Tang	Director	Buy	75,003	$6.80	$510,020.40
1/30/2020	Kevin C Tang	Director	Buy	81,475	$6.72	$547,512.00
1/14/2020	Darryl Wellinghoff	Insider	Buy	3,000	$8.23	$24,690.00	6,545
1/13/2020	Kevin C Tang	Director	Buy	2,971,682	$7.00	$20,801,774.00
1/9/2020	Kevin C Tang	Director	Buy	1,000,000	$4.99	$4,990,000.00

Warning: The Last Value Play Gone After August?

From Oxford Club | Ad

Get the Details Now.

SEC Filings (Institutional Ownership Changes) for La Jolla Pharmaceutical (NASDAQ:LJPC)

97.06% of La Jolla Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

La Jolla Pharmaceutical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/16/2022	Goldman Sachs Group Inc.	13,718	$59K	0.0%	-61.4%	0.054%
5/16/2022	State Street Corp	98,941	$0.42M	0.0%	+4.2%	0.386%
5/13/2022	Renaissance Technologies LLC	26,100	$0.11M	0.0%	-26.5%	0.102%
5/13/2022	Northern Trust Corp	80,053	$0.34M	0.0%	+5.3%	0.312%
5/13/2022	Vanguard Group Inc.	825,481	$3.53M	0.0%	-0.5%	3.222%
5/12/2022	Acadian Asset Management LLC	477,688	$2.04M	0.0%	+9.7%	1.864%
5/12/2022	Running Point Capital Advisors LLC	10,000	$43K	0.0%	N/A	0.039%
5/11/2022	Bank of New York Mellon Corp	127,084	$0.54M	0.0%	+4.8%	0.496%
5/5/2022	HealthInvest Partners AB	707,000	$3.02M	4.8%	-14.8%	2.569%
4/14/2022	Ritholtz Wealth Management	15,031	$64K	0.0%	N/A	0.055%
2/23/2022	BlackRock Inc.	428,769	$1.99M	0.0%	+0.8%	1.558%
2/17/2022	Goldman Sachs Group Inc.	35,577	$0.17M	0.0%	-19.4%	0.129%
2/14/2022	D. E. Shaw & Co. Inc.	588,802	$2.74M	0.0%	-3.6%	2.139%
2/14/2022	Citadel Advisors LLC	61,977	$0.29M	0.0%	+37.7%	0.225%
2/14/2022	Goldman Sachs Group Inc.	35,577	$0.17M	0.0%	-19.4%	0.129%
2/11/2022	Geode Capital Management LLC	283,870	$1.32M	0.0%	+3.1%	1.031%
2/11/2022	Renaissance Technologies LLC	35,500	$0.17M	0.0%	-22.5%	0.129%
2/10/2022	Acadian Asset Management LLC	435,387	$2.02M	0.0%	+18.3%	1.582%
2/10/2022	Globeflex Capital L P	92,799	$0.43M	0.1%	+242.6%	0.337%
2/9/2022	BNP Paribas Arbitrage SA	30,734	$0.14M	0.0%	+15,344.2%	0.112%
2/8/2022	Bank of America Corp DE	14,156	$66K	0.0%	-28.4%	0.051%
1/18/2022	HealthInvest Partners AB	830,000	$3.86M	5.4%	+207.4%	3.016%
1/7/2022	Hollencrest Capital Management	82,355	$0.38M	0.0%	+94.4%	0.299%
11/16/2021	Two Sigma Investments LP	117,094	$0.47M	0.0%	-12.3%	0.425%
11/16/2021	Millennium Management LLC	140,011	$0.56M	0.0%	-65.2%	0.509%
11/15/2021	Morgan Stanley	106,494	$0.43M	0.0%	-59.0%	0.387%
11/15/2021	HighVista Strategies LLC	25,493	$0.10M	0.1%	N/A	0.093%
11/15/2021	GSA Capital Partners LLP	26,143	$0.10M	0.0%	-50.4%	0.095%
11/12/2021	Renaissance Technologies LLC	45,836	$0.18M	0.0%	N/A	0.167%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	10,094	$40K	0.0%	N/A	0.037%
11/10/2021	Goldman Sachs Group Inc.	44,122	$0.18M	0.0%	-69.9%	0.161%
11/9/2021	Barclays PLC	7,704	$30K	0.0%	-47.1%	0.028%
11/9/2021	BlackRock Inc.	425,317	$1.70M	0.0%	+10.6%	1.545%
11/8/2021	HealthInvest Partners AB	270,000	$1.08M	1.6%	N/A	0.982%
10/12/2021	First Midwest Bank Trust Division	41,731	$0.17M	0.0%	+21.9%	0.152%
8/25/2021	Marshall Wace LLP	15,572	$67K	0.0%	N/A	0.057%
8/23/2021	Morgan Stanley	259,753	$1.11M	0.0%	-39.3%	0.945%
8/17/2021	Wells Fargo & Company MN	10,511	$44K	0.0%	-97.2%	0.038%
8/17/2021	Millennium Management LLC	401,819	$1.72M	0.0%	+128.5%	1.462%
8/16/2021	Squarepoint Ops LLC	13,227	$57K	0.0%	-61.1%	0.048%
8/16/2021	Bank of America Corp DE	34,306	$0.15M	0.0%	-34.5%	0.125%
8/16/2021	LMR Partners LLP	11,515	$49K	0.0%	N/A	0.042%
8/16/2021	Morgan Stanley	259,753	$1.11M	0.0%	-39.3%	0.945%
8/16/2021	State Street Corp	93,479	$0.40M	0.0%	-76.4%	0.340%
8/16/2021	Tibra Equities Europe Ltd	72,600	$0.31M	0.1%	N/A	0.264%
8/16/2021	Goldman Sachs Group Inc.	146,525	$0.63M	0.0%	+6.4%	0.533%
8/16/2021	Marshall Wace LLP	15,572	$67K	0.0%	N/A	0.057%
8/13/2021	Northern Trust Corp	74,312	$0.32M	0.0%	-67.4%	0.270%
8/13/2021	Geode Capital Management LLC	274,361	$1.17M	0.0%	-34.1%	0.998%
8/13/2021	Vanguard Group Inc.	884,225	$3.79M	0.0%	-9.7%	3.217%
8/12/2021	JPMorgan Chase & Co.	71,589	$0.31M	0.0%	-14.4%	0.260%
8/12/2021	Ergoteles LLC	82,400	$0.35M	0.0%	N/A	0.300%
8/11/2021	Bank of New York Mellon Corp	71,283	$0.31M	0.0%	-40.8%	0.259%
8/11/2021	Deutsche Bank AG	55,995	$0.24M	0.0%	-18.8%	0.204%
8/10/2021	Employees Retirement System of Texas	56,540	$0.24M	0.0%	-34.9%	0.206%
8/5/2021	GSA Capital Partners LLP	52,749	$0.23M	0.0%	N/A	0.192%
5/19/2021	Virtu Financial LLC	11,843	$50K	0.0%	-62.1%	0.043%
5/19/2021	Squarepoint Ops LLC	33,988	$0.14M	0.0%	N/A	0.124%
5/18/2021	Millennium Management LLC	175,836	$0.75M	0.0%	N/A	0.641%
5/18/2021	D. E. Shaw & Co. Inc.	731,137	$3.10M	0.0%	+75.9%	2.664%
5/18/2021	Morgan Stanley	427,683	$1.81M	0.0%	+5.5%	1.558%
5/18/2021	Cubist Systematic Strategies LLC	16,218	$69K	0.0%	N/A	0.059%
5/18/2021	Jane Street Group LLC	11,173	$47K	0.0%	N/A	0.041%
5/17/2021	Schonfeld Strategic Advisors LLC	16,200	$68K	0.0%	N/A	0.059%
5/17/2021	PDT Partners LLC	10,809	$46K	0.0%	N/A	0.039%
5/17/2021	Nuveen Asset Management LLC	146,256	$0.62M	0.0%	-8.1%	0.533%
5/17/2021	Goldman Sachs Group Inc.	137,650	$0.58M	0.0%	+11.1%	0.501%
5/14/2021	RTW Investments LP	2,327,903	$9.87M	0.2%	-2.9%	8.481%
5/14/2021	Occudo Quantitative Strategies LP	18,113	$77K	0.0%	N/A	0.066%
5/13/2021	Trexquant Investment LP	25,006	$0.11M	0.0%	N/A	0.091%
5/13/2021	Barclays PLC	15,083	$64K	0.0%	+158.6%	0.055%
5/13/2021	Renaissance Technologies LLC	33,600	$0.14M	0.0%	-74.1%	0.122%
5/13/2021	Bank of New York Mellon Corp	120,348	$0.51M	0.0%	+84.0%	0.438%
5/12/2021	Northern Trust Corp	228,088	$0.97M	0.0%	-8.9%	0.831%
5/12/2021	Geode Capital Management LLC	416,587	$1.77M	0.0%	+3.7%	1.518%
5/12/2021	Premier Asset Management LLC	51,305	$0.22M	0.0%	-33.3%	0.187%
5/12/2021	JPMorgan Chase & Co.	83,632	$0.36M	0.0%	+26.7%	0.305%
5/11/2021	Acadian Asset Management LLC	114,946	$0.49M	0.0%	N/A	0.419%
5/7/2021	BlackRock Inc.	1,498,887	$6.36M	0.0%	+1.4%	5.462%
4/29/2021	Hollencrest Capital Management	39,000	$0.17M	0.0%	-20.4%	0.142%
4/15/2021	First Midwest Bank Trust Division	89,341	$0.38M	0.1%	-42.7%	0.326%
4/14/2021	WealthTrust Axiom LLC	30,400	$0.13M	0.0%	N/A	0.111%
2/26/2021	RMR Wealth Builders	9,400	$36K	0.0%	-56.1%	0.034%
2/24/2021	Virtu Financial LLC	31,227	$0.12M	0.0%	N/A	0.114%
2/24/2021	Alyeska Investment Group L.P.	536,847	$2.08M	0.0%	+9.3%	1.961%
2/19/2021	JPMorgan Chase & Co.	66,022	$0.26M	0.0%	-9.6%	0.241%
2/16/2021	Walleye Capital LLC	17,901	$69K	0.0%	N/A	0.065%
2/16/2021	Alyeska Investment Group L.P.	536,847	$2.08M	0.0%	+9.3%	1.961%
2/16/2021	Nuveen Asset Management LLC	159,107	$0.62M	0.0%	+16.5%	0.581%
2/11/2021	Northern Trust Corp	250,427	$0.97M	0.0%	-8.6%	0.915%
2/11/2021	Signaturefd LLC	10,000	$39K	0.0%	-54.5%	0.037%
2/10/2021	Renaissance Technologies LLC	129,953	$0.50M	0.0%	+1,070.7%	0.475%
2/9/2021	Wells Fargo & Company MN	26,253	$0.10M	0.0%	-39.0%	0.096%
2/9/2021	Bank of New York Mellon Corp	65,423	$0.25M	0.0%	-3.8%	0.239%
2/5/2021	BlackRock Inc.	1,477,499	$5.73M	0.0%	+2.5%	5.396%
1/26/2021	Hollencrest Capital Management	49,000	$0.19M	0.0%	+25.6%	0.179%
1/14/2021	First Midwest Bank Trust Division	155,845	$0.61M	0.1%	+431.2%	0.569%
11/17/2020	Tang Capital Management LLC	9,405,490	$37.90M	6.9%	+8.2%	34.350%
11/17/2020	California State Teachers Retirement System	27,276	$0.11M	0.0%	-15.4%	0.100%
11/16/2020	Squarepoint Ops LLC	12,998	$52K	0.0%	N/A	0.047%

Data available starting January 2016

La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older. It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. Its product candidates that are in early stage clinical or preclinical development include TP-6076, an IV formulation of a fully synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria; TP-271, an IV and oral formulation of a fully synthetic fluorocycline for the treatment of respiratory disease caused by bacterial biothreat and antibiotic-resistant public health pathogens, as well as bacterial pathogens associated with community-acquired bacterial pneumonia; and TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia. The company has license agreement with Everest Medicines Limited to develop and commercialize XERAVA; and PAION AG to commercialize GIAPREZA and XERAVA. La Jolla Pharmaceutical Company was incorporated in 1989 and is based in Waltham, Massachusetts.

Today's Range

Now: $3.94

$3.94

$4.08

50 Day Range

MA: $4.17

$3.64

$4.71

52 Week Range

Now: $3.94

$3.40

$5.69

Volume

44,010 shs

Average Volume

67,937 shs

Market Capitalization

$100.71 million

P/E Ratio

26.27

Dividend Yield

N/A

Beta

1.94

Who are the company insiders with the largest holdings of La Jolla Pharmaceutical?: La Jolla Pharmaceutical's top insider shareholders include:
David A Ramsay (Director)
Kevin C Tang (Director)
Learn More about top insider investors at La Jolla Pharmaceutical.
Who are the major institutional investors of La Jolla Pharmaceutical?: La Jolla Pharmaceutical's top institutional investors include:
Vanguard Group Inc. — 3.22%
HealthInvest Partners AB — 2.57%
Acadian Asset Management LLC — 1.86%
Bank of New York Mellon Corp — 0.50%
State Street Corp — 0.39%
Northern Trust Corp — 0.31%
Learn More about top institutional investors of La Jolla Pharmaceutical stock.
Which institutional investors are selling La Jolla Pharmaceutical stock?: In the last quarter, LJPC stock was sold by these institutional investors:
HealthInvest Partners AB
Goldman Sachs Group Inc.
Renaissance Technologies LLC
Vanguard Group Inc.
Which institutional investors are buying La Jolla Pharmaceutical stock?: During the previous quarter, LJPC stock was purchased by institutional investors including:
Acadian Asset Management LLC
Ritholtz Wealth Management
Running Point Capital Advisors LLC
Bank of New York Mellon Corp
Northern Trust Corp
State Street Corp
Within the previous year, these company insiders have bought La Jolla Pharmaceutical stock:
David A Ramsay (Director)
Kevin C Tang (Director)
Learn More investors buying La Jolla Pharmaceutical stock.

How You Should Be Choosing Your Stocks

From Vantage Point | Ad

Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades. We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.

Click here now to join and get access to our forecasting.

LJPC Insider Trading (La Jolla Pharmaceutical)

La Jolla Pharmaceutical Insider Trading History Chart

La Jolla Pharmaceutical Share Price & Price History

La Jolla Pharmaceutical Insider Trading History

SEC Filings (Institutional Ownership Changes) for La Jolla Pharmaceutical (NASDAQ:LJPC)

Institutional Buying and Selling by Quarter

La Jolla Pharmaceutical Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of La Jolla Pharmaceutical?

Who are the major institutional investors of La Jolla Pharmaceutical?

Which institutional investors are selling La Jolla Pharmaceutical stock?

Which institutional investors are buying La Jolla Pharmaceutical stock?